(AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population

[1]  A. Caspi,et al.  Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction , 2005, Biological Psychiatry.

[2]  Diane M. Smith,et al.  Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis , 1990, Psychopharmacology.

[3]  G. Uhl,et al.  Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse , 2004, Molecular Psychiatry.

[4]  Therese Garrick,et al.  Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  R. Murray,et al.  Causal association between cannabis and psychosis: examination of the evidence , 2004, British Journal of Psychiatry.

[6]  H. Ujike,et al.  New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. , 2004, Journal of pharmacological sciences.

[7]  Eduardo L. Franco,et al.  Computer Programs for Epidemiologists–PEPI Version 4.0 , 2003 .

[8]  J. Hoenicka,et al.  Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients , 2003, Molecular Psychiatry.

[9]  M. Palkovits,et al.  A Critical Role for the Cannabinoid CB1 Receptors in Alcohol Dependence and Stress-Stimulated Ethanol Drinking , 2003, The Journal of Neuroscience.

[10]  D. Fergusson,et al.  Cannabis dependence and psychotic symptoms in young people , 2003, Psychological Medicine.

[11]  M. Weiser,et al.  Clinical characteristics of adolescents later hospitalized for schizophrenia. , 2002, American journal of medical genetics.

[12]  Richie Poulton,et al.  Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study , 2002, BMJ : British Medical Journal.

[13]  Glyn Lewis,et al.  Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study , 2002, BMJ : British Medical Journal.

[14]  R. de Graaf,et al.  Cannabis use and psychosis: a longitudinal population-based study. , 2002, American journal of epidemiology.

[15]  J. Samochowiec,et al.  Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. , 2002, Drug and alcohol dependence.

[16]  H Ujike,et al.  CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia , 2002, Molecular Psychiatry.

[17]  P. Gahlinger,et al.  Computer Programs for Epidemiologists: Pepi Version 4.0 , 2001 .

[18]  G. R. Valladolid,et al.  [Treatment of schizophrenia in subjects with substance use disorders: A review]. , 2001 .

[19]  B. Dean,et al.  Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use , 2001, Neuroscience.

[20]  Andrew Johns,et al.  Psychiatric effects of cannabis , 2001, British Journal of Psychiatry.

[21]  S. Tsai,et al.  Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. , 2000, Psychiatric genetics.

[22]  D. Collier,et al.  No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population , 2000, Molecular Psychiatry.

[23]  H. Emrich,et al.  Elevated endogenous cannabinoids in schizophrenia. , 1999, Neuroreport.

[24]  M. Parmentier,et al.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. , 1999, Science.

[25]  E. Gardner Cannabinoid Interaction with Brain Reward Systems , 1999 .

[26]  R. Drake,et al.  Dual diagnosis: a review of etiological theories. , 1998, Addictive behaviors.

[27]  D. Comings,et al.  Cannabinoid receptor gene (CNR1): association with IV drug use , 1997, Molecular Psychiatry.

[28]  D. Comings,et al.  Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential , 1997, Molecular Psychiatry.

[29]  E. Dawson Identification of a highly polymorphic triplet repeat marker for the brain cannabinoid receptor gene: Use in linkage and association studies of schizophrenia , 1995, Schizophrenia Research.

[30]  Peter B. Jones,et al.  Cannabis and acute psychosis , 1994, Schizophrenia Research.

[31]  L. Dixon,et al.  Defining subgroups of dual diagnosis patients for service planning. , 1994, Hospital & community psychiatry.

[32]  P. Dingemans,et al.  Cannabis abuse and the course of recent onset schizophrenic disorders , 1993, Schizophrenia Research.

[33]  A. Ghodse,et al.  Cannabis and psychotic illness , 1992, British Journal of Psychiatry.

[34]  B. Cuffel Prevalence Estimates of Substance Abuse in Schizophrenia and their Correlates , 1992, The Journal of nervous and mental disease.

[35]  N. Andreasen,et al.  Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment , 1992, Psychological Medicine.

[36]  T. Bonner,et al.  Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15. , 1991, The New biologist.

[37]  T Suliman,et al.  Cannabis psychosis following bhang ingestion. , 1991, British journal of addiction.

[38]  M. Tsuang,et al.  Impact of substance abuse on the course and outcome of schizophrenia. , 1990, Schizophrenia bulletin.

[39]  R. Drake,et al.  Substance abuse among the chronic mentally ill. , 1989, Hospital & community psychiatry.

[40]  F. Osher,et al.  Treatment of patients with psychiatric and psychoactive substance abuse disorders. , 1989, Hospital & community psychiatry.

[41]  C. Caton,et al.  Young chronic patients and substance abuse. , 1989, Hospital & community psychiatry.

[42]  M. Test,et al.  Substance use in young adults with schizophrenic disorders. , 1989, Schizophrenia bulletin.

[43]  Sven Andréasson,et al.  CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts , 1987, The Lancet.

[44]  F. Schneier,et al.  A Review of Psychoactive Substance Use and Abuse in Schizophrenia: Patterns of Drug Choice , 1987, The Journal of nervous and mental disease.

[45]  D. Fitzgibbons,et al.  Patterns of drug use in a population of youthful psychiatric patients. , 1972, American Journal of Psychiatry.

[46]  D. W. Goodwin,et al.  Marihuana use and psychiatric illness. , 1972, Archives of general psychiatry.